LCM
ELV icon

Laurion Capital Management’s Elevance Health ELV Stock Holding History

Laurion Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,550
Closed -$603K – 308
2025
Q2 		$603K Buy
+1,550
New +$623K 0.01% 229
2024
Q3 		– Sell
-2,914
Closed -$1.58M – 399
2024
Q2 		$1.58M Buy
+2,914
New +$1.54M 0.02% 253
2024
Q1 		– Sell
-15,985
Closed -$7.54M – 551
2023
Q4 		$7.54M Buy
+15,985
New +$7.39M 0.06% 213
2021
Q3 		– Sell
-624
Closed -$238K – 746
2021
Q2 		$238K Buy
+624
New +$238K ﹤0.01% 632
2021
Q1 		– Sell
-1,343
Closed -$431K – 787
2020
Q4 		$431K Sell
1,343
-5,373
-80% -$1.65M ﹤0.01% 502
2020
Q3 		$1.8M Sell
6,716
-3,228
-32% -$869K 0.02% 327
2020
Q2 		$2.62M Buy
+9,944
New +$2.65M 0.03% 300
2019
Q2 		– Sell
-4,400
Closed -$1.2M – 956
2019
Q1 		$1.26M Sell
4,400
-3,335
-43% -$965K 0.02% 473
2018
Q4 		$2.03M Buy
7,735
+5,735
+287% +$1.58M 0.04% 439
2018
Q3 		$548K Sell
2,000
-14,816
-88% -$3.85M 0.01% 809
2018
Q2 		$4M Sell
16,816
-1,460
-8% -$338K 0.03% 405
2018
Q1 		$4.01M Sell
18,276
-25,524
-58% -$6M 0.03% 421
2017
Q4 		$9.86M Buy
43,800
+4,400
+11% +$937K 0.05% 345
2017
Q3 		$7.48M Buy
39,400
+24,900
+172% +$4.74M 0.03% 389
2017
Q2 		$2.73M Buy
+14,500
New +$2.61M 0.01% 712
2017
Q1 		– Sell
-1,400
Closed -$201K – 1368
2016
Q4 		$201K Buy
+1,400
New +$187K ﹤0.01% 1007
2015
Q2 		– Sell
-208,100
Closed -$33.2M – 632
2015
Q1 		$32.1M Buy
+208,100
New +$29.6M 0.63% 45
2014
Q1 		– Sell
-4,418
Closed -$408K – 262
2013
Q4 		$408K Buy
4,418
+884
+25% +$78.5K 0.01% 158
2013
Q3 		$295K Buy
+3,534
New +$303K 0.02% 140

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Laurion Capital Management's ELV Position: Q3 2025 in Review

Laurion Capital Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,550 shares — an estimated $603K sold.

Laurion Capital Management first reported a position in ELV in Q3 2013 and held it in 19 quarters. The position peaked at $32.1M in Q1 2015. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Laurion Capital Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Laurion Capital Management sold 1,550 Elevance Health shares in Q3 2025, an estimated $603K.
  • Laurion Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 19 quarters.
  • Laurion Capital Management's Elevance Health position peaked at $32.1M in Q1 2015.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.